Publications by the researcher in collaboration with Paula Ortega Lopez (55)

2023

  1. Carbosilane dendritic nanostructures, highly versatile platforms for pharmaceutical applications

    Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Vol. 15, Núm. 3

2022

  1. Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts

    Scientific Reports, Vol. 12, Núm. 1

  2. Heterofunctional carbosilane polyphenolic dendrons: new antioxidants platforms

    RSC Advances, Vol. 12, Núm. 17, pp. 10280-10288

  3. Inhibition of Candida glabrata Biofilm by Combined Effect of Dendritic Compounds and Amphotericin

    Pharmaceutics, Vol. 14, Núm. 8

2021

  1. Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons

    Biomacromolecules, Vol. 22, Núm. 11, pp. 4582-4591

  2. Eradication of candida albicans biofilm viability: In vitro combination therapy of cationic carbosilane dendrons derived from 4-phenylbutyric acid with agno3 and edta

    Journal of Fungi, Vol. 7, Núm. 7

  3. Erratum to: Antioxidant and antibacterial properties of carbosilane dendrimers functionalized with polyphenolic moieties (Pharmaceutics 2020, 12, 698)

    Pharmaceutics

2020

  1. Antioxidant and antibacterial properties of carbosilane dendrimers functionalized with polyphenolic moieties

    Pharmaceutics, Vol. 12, Núm. 8, pp. 1-16

  2. CHAPTER 5: Poly(carbosilane) dendrimers and other silicon-containing dendrimers

    Monographs in Supramolecular Chemistry, Vol. 2020-January, Núm. 29, pp. 114-145

  3. Cationic Carbosilane Dendritic Systems as Promising Anti-Amyloid Agents in Type 2 Diabetes

    Chemistry - A European Journal, Vol. 26, Núm. 34, pp. 7609-7621

  4. Copper (II) metallodendrimers combined with pro-apoptotic sirnas as a promising strategy against breast cancer cells

    Pharmaceutics, Vol. 12, Núm. 8, pp. 1-14

  5. Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer

    European Journal of Medicinal Chemistry, Vol. 199

  6. Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer

    European Journal of Medicinal Chemistry, Vol. 207

2019

  1. Antibacterial effect of carbosilane metallodendrimers in planktonic cells of gram-positive and gram-negative bacteria and staphylococcus aureus biofilm

    Biomolecules, Vol. 9, Núm. 9

  2. Carbosilane Dendron-Peptide Nanoconjugates as Antimicrobial Agents

    Molecular Pharmaceutics, Vol. 16, Núm. 6, pp. 2661-2674

  3. Exploring the interactions of ruthenium (II) carbosilane metallodendrimers and precursors with model cell membranes through a dual spin-label spin-probe technique using EPR

    Biomolecules, Vol. 9, Núm. 10

  4. Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models

    Nanoscale, Vol. 11, Núm. 28, pp. 13330-13342

  5. Nanosystems as vehicles for the delivery of antimicrobial peptides (Amps)

    Pharmaceutics, Vol. 11, Núm. 9

  6. Synthesis and characterization of FITC labelled ruthenium dendrimer as a prospective anticancer drug

    Biomolecules, Vol. 9, Núm. 9

  7. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini

    Parasitology Research, Vol. 118, Núm. 6, pp. 1953-1961